8641502

Deaton JL

1996

Serum from women with polycystic ovary syndrome inhibits fertilization and embryonic development in the murine in vitro fertilization model.

8641511

Kaaijk EM

1996

Further thoughts on surgical therapy for polycystic ovary syndrome.

8641512

Balen A

1996

Further thoughts on surgical therapy for polycystic ovary syndrome.

8641513

Van der Wat J

1996

Further thoughts on surgical therapy for polycystic ovary syndrome.

8654631

Barreca A

1996

Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome.

8671152

Holte J

1996

Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?

8671153

Homburg R

1996

Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy.

8671237

Farhi J

1996

Treatment of anovulatory infertility: the problem of multiple pregnancy.

8671248

Homburg R

1996

Opinion. Polycystic ovary syndrome

8671250

van Dessel HJ

1996

Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.

8671313

Homburg R

1996

Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.

8671356

Battaglia C

1996

Colour Doppler imaging and polycystic ovary syndrome.

8671357

Zaidi J

1996

Letter. Colour Doppler imaging and polycystic ovary syndrome

8671376

Saravelos H

1996

Post-operative adhesions after laparoscopic electrosurgical treatment for polycystic ovarian syndrome with the application of Interceed to one ovary: a prospective randomized controlled study.

8671420

Birdsall MA

1996

Antiphospholipid antibodies in women having in-vitro fertilization.

8671472

Takayama K

1996

Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.

8672905

Rossmanith WG

1995

[Clinical and endocrine effects of laparoscopic ovarian surgery in patients with polycystic ovary syndrome].

8675076

Goluda M

1995

[A rare case of concurrent endometrial carcinoma and PCO syndrome].

8677828

Kalve E

1996

Evaluation of women with hirsutism.

8680455

Bj?rntorp P

1996

The regulation of adipose tissue distribution in humans.

8682342

Katulski K

1995

[Molecular basis of polycystic ovarian syndrome].

8682343

Maciejewska M

1995

[Pharmacologic treatment for polycystic ovary syndrome].

8687515

Nestler JE

1996

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

8687522

Utiger RD

1996

Insulin and the polycystic ovary syndrome.

8688808

Campion CE

1996

Effects of follicle-stimulating hormone administration on oestradiol-induced cystic ovaries in guinea pigs.

8692506

Tan SL

1996

Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.

8698271

Laohaprasitiporn C

1996

Induction of ovulation with the sole use of clomiphene citrate in late-onset 21-hydroxylase deficiency.

8699135

Sawetawan C

1996

Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylase expression in human ovarian thecal-like tumor cells.

8706299

Rajkhowa M

1996

Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.

8719011

Grunwald K

1994

[Serum hormones before and during therapy with cyproterone acetate and spironolactone in patients with androgenization].

8721909

Imai A

1995

Ultrasound-detected polycystic ovarian syndrome associated with depleted basal level but enhanced response of gonadotropin.

8723512

Herter LD

1996

Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders.

8728917

Wu X

1995

[Responses of somatostatin, beta-endorphin and dynorphin A to A glucose load in two groups of women with polycystic ovarian syndrome].

8729521

Birdsall MA

1996

Polycystic ovaries in pre and post-menopausal women.

8729522

Robinson S

1996

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

8729717

Olukoga AO

1996

Differences in serum luteinizing hormone measurements by immunoradiometric assay induced by kinetic manipulation of assay conditions are dependent on the endocrine milieu of serum.

8730621

Yapar EG

1996

Hyperreactio luteinalis masquerading as an ovarian neoplasm in a triplet pregnancy.

8731178

Homburg R

1996

Polycystic ovary syndrome.

8731709

Gatee OB

1996

Hirsutism in the United Arab Emirates: a hospital study.

8735740

Carranza-Lira S

1996

The relation of the gonadotrophin response to chlormadinone according to body weight in patients with amenorrhea due to polycystic ovarian syndrome.

8736268

Prelevic GM

1995

Cardiac flow velocity in women with the polycystic ovary syndrome.

8737187

Zullo F

1996

Superovulation with urinary human follicle-stimulating hormone: correlations with body mass index and body fat distribution.

8739463

Roussev RG

1996

Laboratory evaluation of women experiencing reproductive failure.

8742124

Homburg R

1996

Growth hormone and fertility--clinical studies.

8743278

Tropeano G

1996

Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels.

8743374

Olivari N

1996

Simultaneous laparoscopic cholecystectomy and laparoscopically assisted vaginal hysteroadnexectomy.

8747032

de Koning J

1995

Gonadotrophin surge-inhibiting/attenuating factor governs luteinizing hormone secretion during the ovarian cycle: physiology and pathology.

8747073

Ben-Chetrit A

1995

Recurrent maternal virilization during pregnancy associated with polycystic ovarian syndrome: a case report and review of the literature.

8751729

Gonzalez F

1996

Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome.

8751755

Whitehead SA

1996

Endometriosis and polycystic ovary syndrome: enhanced stimulatory effect of peritoneal fluid on progesterone release from human granulosa-lutein cells.

8752611

Ruchhoft EA

1996

Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.

8752612

Tolino A

1996

Finasteride in the treatment of hirsutism: new therapeutic perspectives.

8759402

Zergollern L

1996

[The genetics of polycystic ovaries].

8759404

Cabrijan T

1996

[Androgen excess in women and the metabolic syndrome (syndrome X)].

8759405

Aganovi? I

1996

[Polycystic ovary syndrome: a disorder of insulin action and an increased risk for onset of non-insulin-dependent diabetes].

8759408

Kupesi? S

1996

[Polycystic ovary syndrome--Doppler parameters].

8759411

Giljevi? Z

1996

[Tests of adrenal gland and ovarian function in the hyperandrogenemia syndrome].

8760715

Wu XK

1996

Wedge resection to improve insulin resistance in polycystic ovary syndrome: a study among Chinese women.

8762734

Almahbobi G

1996

Functional integrity of granulosa cells from polycystic ovaries.

8768842

Morales AJ

1996

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

8772555

Dunaif A

1996

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

8772557

Moghetti P

1996

The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

8772565

Voutilainen R

1996

Expression of insulin-like growth factor (IGF), IGF-binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries.

8772605

Ibanez L

1996

Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.

8773744

Franks S

1996

Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha.

8773745

Soule SG

1996

Neuroendocrinology of the polycystic ovary syndrome.

8773746

Holte J

1996

Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.

8773747

Kyei-Mensah A

1996

Ultrasound diagnosis of polycystic ovary syndrome.

8773748

Conway GS

1996

Polycystic ovary syndrome: clinical aspects.

8773749

Homburg R

1996

Polycystic ovary syndrome: induction of ovulation.

8773750

Donesky BW

1996

Surgical ovulation induction: the role of ovarian diathermy in polycystic ovary syndrome.

8773751

McKeigue P

1996

Cardiovascular disease and diabetes in women with polycystic ovary syndrome.

8774098

van der Westhuizen S

1996

Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.

8774099

Battaglia C

1996

Color Doppler analysis in lean and obese women with polycystic ovary syndrome.

8774278

Aleem FA

1996

Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease.

8774279

Koskinen P

1996

Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome.

8777787

Tartagni M

1995

Induction of multifollicular growth in patients non responding to clomiphene citrate and gonadotropins or gonadotropins only.

8784087

Dunaif A

1996

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

8784876

Minchoff LE

1996

Syndrome X. Recognition and management of this metabolic disorder in primary care.

8791980

Gama R

1996

The entero-insular axis in polycystic ovarian syndrome.

8796141

Lanzone A

1996

Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.

8796926

Guzick DS

1996

Cardiovascular risk in women with polycystic ovarian syndrome.

8816612

Paoletti AM

1996

The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.

8816616

Avivi I

1996

Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing.

8816617

Martikainen H

1996

Adrenal steroidogenesis is related to insulin in hyperandrogenic women.

8816618

van der Meer M

1996

The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.

8817683

Giudice LC

1995

Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome.

8817738

Michael A

1996

Bisexual erotomania with polycystic ovary disease.

8818524

Zaidi J

1996

Advances in the use of ultrasound in infertility management.

8820990

Nakagawa Y

1996

Detection of an aberrant fragment in growth hormone gene cluster in a girl with congenital generalized lipodystrophy.

8829697

Derman RJ

1996

Androgen excess in women.

8831007

Harrington DJ

1996

Polycystic ovary syndrome: aetiology and management.

8834837

Banaczek Z

1995

[Internal endometriosis from personal material].

8838872

Prapas Y

1994

Ovarian hyperstimulation syndrome and heterotopic pregnancy after IVF.

8841217

Schildkraut JM

1996

Epithelial ovarian cancer risk among women with polycystic ovary syndrome.

8845652

Parra A

1995

Serum androgen changes during meal-induced hyperinsulinemia and after acute sequential blockade and hyperstimulation of insulin release in women with polycystic ovary syndrome.

8855823

Agarwal SK

1996

A mechanism for the suppression of estrogen production in polycystic ovary syndrome.

8862498

Ambrosi B

1996

Value of buserelin testing in the evaluation of hirsute women.

8869364

Manieri C

1995

A new approach in the evaluation of gonadotropins for the diagnosis of polycystic ovary syndrome.

8871183

Wu XK

1996

Responses of somatostatin, beta-endorphin and dynorphin A to a glucose load in two groups of women with polycystic ovarian syndrome.